Stimcell Energetics (STME) Assets (QoQ) (2011 - 2026)
Stimcell Energetics (STME) Assets (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -34.05% |
| Nov 30, 2025 | 219.43% |
| Aug 31, 2025 | -22.78% |
| May 31, 2025 | 24.03% |
| Feb 28, 2025 | -55.38% |
| Nov 30, 2024 | 71.21% |
| Aug 31, 2024 | -51.44% |
| May 31, 2024 | -43.70% |
| Feb 29, 2024 | 257.99% |
| Nov 30, 2023 | -63.28% |
| Aug 31, 2023 | -39.65% |
| May 31, 2023 | 643.16% |
| Feb 28, 2023 | -42.15% |
| Nov 30, 2022 | -15.94% |
| Aug 31, 2022 | -30.88% |
| May 31, 2022 | -24.69% |
| Feb 28, 2022 | -24.35% |
| Nov 30, 2021 | -28.78% |
| Aug 31, 2021 | 95.05% |
| May 31, 2021 | -47.78% |